ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Breakout Labs, an early-stage science investment fund created by billionaire Peter Thiel, is investing in four new companies. Azitra is tapping the skin microbiome to develop treatments for skin disorders; Opus 12, founded by three Stanford University students, has developed a reactor to transform carbon dioxide into chemicals and fuel; Seatrec is trying to eliminate our dependence on lithium batteries with its thermal recharging technology; and ZymoChem is engineering microbes to produce chemicals. Each company will get up to $350,000 over two years to support its research.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter